echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Cefprozil dry suspension, a wholly-owned subsidiary of Shanghai Modern Pharmaceutical, passed the consistency evaluation of generic drugs

    Cefprozil dry suspension, a wholly-owned subsidiary of Shanghai Modern Pharmaceutical, passed the consistency evaluation of generic drugs

    • Last Update: 2021-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On October 19, Shanghai Modern Pharmaceutical issued an announcement stating that its wholly-owned subsidiary Sinopharm Jinshi received the Cefprozil Dry Suspension (0.
    125g) "Drug Supplementary Application Approval Notice" approved and issued by the State Drug Administration, and approved the The drug passed the consistency evaluation of generic drugs
    .

    Cefprozil is a long-acting, broad-spectrum second-generation cephalosporin antibiotic.
    It is generally used clinically to treat infectious diseases caused by sensitive bacteria, including upper respiratory tract infections, lower respiratory tract infections, and skin and soft tissue infections
    .


    The drug was first developed by Bristol-MyersSquibb in the United States, and was first marketed in the United States in 1991


    According to data from the PDB Drug Comprehensive Database, global sales of cefprozil dry suspension in 2020 will be 117.
    2 million U.
    S.
    dollars; domestic sample hospital sales will be 130.
    9 million yuan
    .

    According to the CDE website, Nanjing Yihua Pharmaceutical Co.
    , Ltd.
    and Hainan Rizhongtian Pharmaceutical Co.
    , Ltd.
    also have passed the consistency evaluation of cefprozil dry suspension (0.
    125g)
    .


    Sinopharm Jinshi used to carry out the consistency evaluation of cefprozil dry suspension (0.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.